Chronic renal failure F3: Chronic renal failure, anemia with CFS (chronic fatigue syndrome), chills, angina, coronary heart disease and weak voice.
1. Renal and urinary problems: Many clinical reports prove F3 can help CRF (chronic renal failure) patients in many ways, especially in VE, LPO, Na, K and ATP enzymes. Of 25 CRF patients taking F3 for 3 weeks, 16 improved. F4 can help not only in nitrogen metabolsim, but also in improving Hb, poor appetite, depression and low sex performance. Of 12 patients taking F3 and a comparison group taking regular medicine, the improvement rate was: 83.3% versus 41.7%, p<0.01. Another 29 patients showed similar results (85.7% versus 53.3%). 45 patients with senile incontinence took F3 and another formula for up to eight weeks. 34 were cured (75.55%), 6 significantly improved (13.33%), 3 improved and 2 did not respond (4.44%).
2. Anemia: In a CFU-D test of lab mice, the treatment group had 65.1% higher output than the comparison group. The average CFU-E and BFU-E were much lower than normal healthy people in 12 CRF (chronic renal failure) patients. After treatment with F3, however, the average RBC, WBC, CFU-E, BFU-E and Hemoglobin were all improved. Of 17 chronic anemia patients taking F3 or its modification, 7 were basically cured with no blood transfusion needed (41.18%), 4 significantly improved (23.52%), 4 improved (23.52%) and 2 did not improve (11.77%). 204 low WBC counts patients were divided into a treatment group (n=120) taking F3 and a comparison group (n=84) using western medicine. Significantly improved: 68 vs. 27 (56.67% vs. 32.14%), improved : 43 vs. 29 (35.83% vs. 34.52%) and not improved: 9 vs. 28 (7.5% vs. 33.33%). There are significant differences between two groups, p<0.01.
3. Heart function: Several studies show F3 can help the heart pump more blood without increasing the heart rate and BP. It does so without demanding more oxygen. Of 54 angina patients taking F3, the total effective rate against palpitations, chest pain, tight chest, shortness of breath and excessive sweating was 89.1%. Overall EKG improvement rate was 88.8%.
4. Chronic Hepatitis B: Of 7 chronic hepatitis B patients taking F3 formula for six weeks, all improved with normal liver test results.
5. Postpartum fever: 90 females with postpartum fever symptoms took F3 for 7 days. 62 (68.88%) were cured. 24 (26.67%) improved and 4 (4.44%) did not.
Toxicity and side effects: There are no reported side effects or toxicity of F3. A very safe formula.
